CL 8-K Current Reports
COLGATE PALMOLIVE CO - 225 current reports
COLGATE PALMOLIVE CO 8-K Report, Shareholder Vote Results (May 13, 2026)
Colgate-Palmolive Co. (CL) filed an 8-K on May 13, 2026, detailing the results of its Annual Meeting of Stockholders held on May 8, 2026. The meeting primarily focused on routine governance matters. All incumbent directors standing for re-election were approved by a significant margin, indicating strong shareholder confidence in the current board's leadership and strategy. Furthermore, the company's choice of PricewaterhouseCoopers LLP as its independent auditor for the upcoming fiscal year was overwhelmingly ratified. Shareholders also provided a non-binding advisory approval for the company's executive compensation. Importantly, two significant shareholder proposals, one concerning the removal of Diversity, Equity, and Inclusion (DEI) from board candidate considerations and another advocating for an independent board chairman, failed to gain majority support, suggesting that the current board's approach to these matters aligns with the majority of the company's voting shareholders.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (May 1, 2026)
Colgate-Palmolive Company (CL) has filed an 8-K report detailing its financial results for the quarter ended March 31, 2026, alongside an expanded productivity program. The press release, incorporated by reference, provides the earnings information investors will be focused on. A key development is the significant expansion of the "Strategic Growth and Productivity Program," originally approved in July 2025. The estimated cumulative pre-tax charges for this program have increased from a range of $200 million-$300 million to $350 million-$550 million. This expansion reflects a commitment to further operational alignment, supply chain optimization, and overhead cost reduction to support the company's 2030 strategy. The charges are primarily related to employee severance and termination benefits, with a smaller portion allocated to asset write-offs and other exit costs. While the majority of these charges are expected to be cash expenditures, the company emphasizes that substantially all will be incurred by the end of 2028. Investors should monitor the company's execution of this expanded program and its impact on future financial performance and cost efficiencies.
COLGATE PALMOLIVE CO 8-K Report, Executive Changes (Apr 9, 2026)
Colgate-Palmolive Company (CL) announced a significant leadership transition within its legal department. Jennifer M. Daniels, the long-serving Chief Legal Officer and Secretary since 2014, has informed the company of her intention to retire in 2026. This departure marks the end of an era for a key executive who has guided the company's legal affairs for over a decade. In response to Ms. Daniels' upcoming retirement, the Board of Directors has elected Betsy Fishbone, currently the Executive Vice President and Deputy Chief Legal Officer, to succeed her as Chief Legal Officer and Secretary, effective June 1, 2026. To ensure a seamless handover and leverage Ms. Daniels' extensive experience, she will transition to the role of Vice Chair of the Company, also effective June 1, 2026. This move is designed to facilitate an orderly transition of responsibilities and maintain continuity in the company's legal leadership.
COLGATE PALMOLIVE CO 8-K Report, Corporate Update (Mar 17, 2026)
Colgate-Palmolive Company (CL) has announced a realignment of its reportable operating segments, effective for the first quarter of fiscal year 2026. This strategic move, part of its previously announced Strategic Growth and Productivity Program, aims to optimize operating scale and drive growth within its global markets. The primary change involves combining the Europe and Africa/Eurasia segments (with specific exclusions) and the Skin Health business into a new, consolidated 'Europe, Middle East and Africa' reportable operating segment. Furthermore, Russia and Belarus operations, previously under Africa/Eurasia, will now be reported within the Asia Pacific segment. Investors should note that this realignment is purely a reporting change and does not affect the Company's historical consolidated financial results, including operations, financial position, or cash flows. Colgate-Palmolive has provided recast historical segment data to facilitate comparison with the new structure.
COLGATE PALMOLIVE CO 8-K Report, Executive Changes (Mar 12, 2026)
Colgate-Palmolive Company (CL) has announced a significant change in its Board of Directors. Effective March 15, 2026, Dr. Christopher S. Boerner, currently the Board Chair and CEO of Bristol-Myers Squibb, will join the Colgate-Palmolive Board. Dr. Boerner's extensive experience in global business leadership, particularly within the biopharmaceutical and healthcare sectors, is expected to bring valuable expertise to the company's strategic direction. In conjunction with this appointment, Steven A. Cahillane has informed the Board that he will not seek reelection at the upcoming Annual Meeting of Stockholders on May 8, 2026. This decision is attributed to the increased demands of his new role as CEO of The Kraft Heinz Company. These board-level transitions signal a refresh in leadership perspective and potentially a strengthened focus on areas complementary to Colgate-Palmolive's existing business.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Jan 30, 2026)
Colgate-Palmolive Company (CL) has filed an 8-K report on January 30, 2026, to announce its financial results for the quarter and full year ended December 31, 2025. The core of this filing is the press release (Exhibit 99) containing these results, which provides investors with key performance metrics and financial condition updates. While the specific details of the earnings are not included in the 8-K text itself, this filing serves as the official notification and incorporation of that information by the company into its SEC disclosures.
COLGATE PALMOLIVE CO 8-K Report, Corporate Update (Nov 10, 2025)
Colgate-Palmolive Company (CL) has filed an 8-K report detailing a significant debt financing transaction. On November 3, 2025, the company entered into an underwriting agreement for the issuance and sale of €600,000,000 of 3.250% Senior Notes due 2035. This offering was made under the company's existing automatic shelf registration statement on Form S-3. These notes were issued on November 10, 2025, under an indenture dated November 15, 1992. The underwriting agreement includes standard provisions for representations, warranties, covenants, and indemnification from both the company and the underwriters. This filing provides transparency on the terms of the debt issuance and the associated legal documentation.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Oct 31, 2025)
Colgate-Palmolive Company (CL) filed an 8-K on October 31, 2025, reporting on its financial results for the quarter ended September 30, 2025, via an attached press release. Investors should note the company is also providing updates on its previously disclosed Strategic Growth and Productivity Program. This program, approved in July 2025, aims to enhance growth and support its 2030 strategy through organizational alignment, supply chain optimization, and cost reduction. The company anticipates cumulative pre-tax charges between $200 million and $300 million related to this program, with a significant portion (75% to 85%) expected to involve cash expenditures and substantially all charges incurred by the end of 2028. The charges are primarily composed of employee-related costs and asset-related charges, with a global distribution across various geographical segments and its Hill's Pet Nutrition business.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Aug 1, 2025)
Colgate-Palmolive Company (CL) has filed an 8-K report highlighting two key events. The first pertains to the release of their earnings for the second quarter ended June 30, 2025, as detailed in a press release attached as an exhibit. While specific financial figures from this press release are not detailed within the 8-K text itself, this filing serves as notification to investors about the availability of this crucial quarterly performance data. The second, and more significant, announcement details the approval of a new three-year "Productivity Program" by the Board of Directors. This program, effective immediately and extending through 2028, aims to enhance future growth by optimizing the global supply chain, streamlining organizational structure, and reducing overhead costs. The company anticipates cumulative pre-tax charges between $200 million and $300 million to be recognized over the program's duration, primarily recorded in the Corporate segment and not impacting internal segment operating performance metrics.
COLGATE PALMOLIVE CO 8-K Report, Executive Changes (May 29, 2025)
Colgate-Palmolive Company (CL) announced a significant executive appointment and a planned retirement, signaling strategic shifts in its leadership. The company has appointed Shane Grant as its new Chief Operating Officer, Americas, effective June 16, 2025. Mr. Grant brings extensive international experience from leadership roles at Danone and The Coca-Cola Company, most recently serving as Group Deputy CEO and CEO Americas at Danone. In addition, Prabha Parameswaran, currently Group President, Growth and Strategy, will transition to Vice Chair effective June 16, 2025, ahead of her planned retirement on October 1, 2025. The company has also made other executive promotions, including Panagiotis Tsourapas to Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development, and John Hazlin to Chief Growth Officer, both effective June 16, 2025. These appointments suggest a focus on strengthening regional operations and driving global growth initiatives.
COLGATE PALMOLIVE CO 8-K Report, Shareholder Vote Results (May 14, 2025)
Colgate-Palmolive Company (CL) has filed an 8-K detailing the results of its Annual Meeting of Stockholders held on May 9, 2025. The meeting focused on routine corporate governance matters, including the election of directors, ratification of the independent auditor, and advisory votes on executive compensation and specific stockholder proposals. All incumbent directors proposed for re-election were overwhelmingly approved, indicating strong shareholder confidence in the current leadership and board composition. The company's choice of PricewaterhouseCoopers LLP as its auditor for the upcoming fiscal year was also ratified with substantial support.
COLGATE PALMOLIVE CO 8-K Report, Corporate Update (May 2, 2025)
Colgate-Palmolive Company (CL) has announced the successful issuance and sale of $500,000,000 aggregate principal amount of its 4.200% Senior Notes due 2030. This debt offering was completed under the Company's existing automatic shelf registration statement and was formalized through an underwriting agreement with Citigroup Global Markets Inc. and Scotia Capital (USA) Inc. as representatives of the underwriters. The issuance of these notes, which matures in 2030, is a standard capital markets transaction intended to support the company's ongoing operations and strategic initiatives. Investors should note that this 8-K filing primarily concerns the details of this debt issuance, including the underwriting agreement and the terms of the notes. While it does not disclose any new financial performance metrics or strategic shifts, it signals the company's proactive approach to managing its capital structure and securing funding. The fixed coupon rate of 4.200% provides a clear cost of debt for this issuance, and the transaction is subject to customary representations, warranties, and indemnification clauses.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Apr 25, 2025)
Colgate-Palmolive Company (CL) has filed an 8-K report on April 24, 2025, to announce its financial results for the quarter ended March 31, 2025. The key details of these results are provided in a press release, attached as Exhibit 99, which is incorporated by reference into this filing. Investors should refer to this press release for specific financial performance metrics and management's commentary on the company's operational and financial condition during the period. While the 8-K itself is a standard notification of the earnings release, it does not contain the detailed financial tables or qualitative analysis. The press release serves as the primary source of information for investors seeking to understand Colgate-Palmolive's performance, including revenue, profitability, and any forward-looking statements or strategic updates. The filing also includes the standard Cover Page Interactive Data File.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Jan 31, 2025)
Colgate-Palmolive Company (CL) has filed an 8-K report on January 31, 2025, to announce its financial results for the quarter and full year ended December 31, 2024. The core of this filing is the press release, incorporated by reference as Exhibit 99, which provides the detailed earnings information that investors will be looking to analyze. While the 8-K itself is brief, serving primarily as a notification and attachment of the earnings release, the press release contains the critical financial metrics such as revenue, earnings per share (EPS), and potentially guidance for the upcoming fiscal year. Investors should refer to the attached press release for specific performance figures and management commentary on the company's operational and financial condition.
COLGATE PALMOLIVE CO 8-K/A Report, Financial Results (Jan 24, 2025)
This 8-K/A filing from Colgate-Palmolive (CL) serves as an amendment, primarily to provide updated financial reporting information and clarify segment reporting changes. The most significant update for investors relates to the earnings for the quarter ended September 30, 2024, as announced in a press release dated October 25, 2024. While the earnings details themselves are incorporated by reference via Exhibit 99.1, the filing confirms that this information has been officially communicated. Furthermore, the company has realigned its skin health business reporting structure, effective July 1, 2024. This change consolidates previously dispersed skin health operations into the North America reportable operating segment. It's crucial to note that this realignment, while affecting segment reporting, does not alter the company's overall consolidated financial results or position. The company has provided recast historical segment information (Exhibit 99.2) for consistency with the new structure, allowing investors to analyze performance on a comparable basis.
COLGATE PALMOLIVE CO 8-K Report, Corporate Update (Oct 25, 2024)
Colgate-Palmolive Company (CL) filed an 8-K on October 25, 2024, to announce its financial results for the quarter ended September 30, 2024. The core of the filing pertains to the earnings press release, which is incorporated by reference. While specific financial figures are not detailed within the 8-K text itself, investors should note that this filing serves as the official notification of these results, typically accompanied by detailed performance metrics, revenue, and profit figures discussed in the press release. Additionally, the company disclosed a change in its reporting structure for the skin health business, effective July 1, 2024. This change involves realigning the skin health business results from the Europe segment to the North America segment. Importantly, this realignment does not impact Colgate-Palmolive's consolidated financial results or position. The company has provided recast historical segment information to offer investors a consistent view under the new structure, which is included as an exhibit. Investors should consult the referenced press release (Exhibit 99.1) for the actual financial performance data and the recast segment information (Exhibit 99.2) for a clearer understanding of segment reporting going forward.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Jul 26, 2024)
Colgate-Palmolive Company (CL) has filed an 8-K report on July 26, 2024, primarily to disclose its financial results for the quarter ended June 30, 2024. The company issued a press release on July 26, 2024, detailing these results, which is attached as an exhibit to this filing. Investors should refer to this press release for specific financial performance metrics, including revenue, profitability, and any segment-specific updates. While the 8-K itself does not provide the detailed financial figures, it serves as the official notification and incorporation by reference of the earnings announcement. Investors interested in the company's performance should consult the full press release (Exhibit 99) for comprehensive information regarding the second quarter of 2024. The filing also notes that the information furnished under Item 2.02 is not considered "filed" for certain regulatory purposes and will not be incorporated into other registration statements.
COLGATE PALMOLIVE CO 8-K Report, Shareholder Vote Results (May 15, 2024)
Colgate-Palmolive Company (CL) filed an 8-K report on May 14, 2024, detailing the outcomes of its Annual Meeting of Stockholders held on May 10, 2024. The report indicates strong support for the company's slate of directors, with all nominated individuals elected to the board. Additionally, shareholders overwhelmingly ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the upcoming fiscal year. The company's executive compensation plan received advisory approval from stockholders, reflecting a positive sentiment towards the remuneration structure. However, a stockholder proposal advocating for an independent Board Chairman was not approved, suggesting a preference for the current governance model among a significant portion of the voting shareholders. These results provide a clear picture of shareholder sentiment on key governance and oversight matters.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Apr 26, 2024)
Colgate-Palmolive Company (CL) has filed an 8-K report on April 26, 2024, to announce its first-quarter 2024 financial results. The core of this filing is a press release issued on the same date, which details the company's performance for the period ending March 31, 2024. Investors should refer to this press release, attached as Exhibit 99, for specific financial figures, operational updates, and management commentary regarding the quarter. While this 8-K primarily serves to incorporate the earnings press release, it is crucial for investors to examine the details within that document. This includes key financial metrics, sales performance across different segments and geographies, profitability, and any forward-looking statements or guidance provided by the company. The filing itself notes that the information furnished under Item 2.02 is not considered 'filed' for certain regulatory purposes, underscoring the importance of the press release as the primary source of detailed results.
COLGATE PALMOLIVE CO 8-K Report, Executive Changes (Feb 15, 2024)
Colgate-Palmolive Company (CL) announced a significant change to its Board of Directors through an 8-K filing on February 15, 2024. The company has elected Brian Newman, the current Executive Vice President and Chief Financial Officer of United Parcel Service, Inc. (UPS), to join the Board effective March 15, 2024. Mr. Newman brings a wealth of financial and global leadership experience, particularly with 26 years at PepsiCo in various finance and operational roles, which is expected to be highly valuable to Colgate's strategic direction and oversight. This addition of new talent to the Board comes as a result of a planned retirement. Stephen I. Sadove, a current director, will retire at the end of his term and will not seek re-election at the upcoming Annual Meeting of Stockholders on May 10, 2024, in accordance with the company's mandatory director retirement policy. These board transitions are designed to ensure continued strong governance and strategic guidance for Colgate-Palmolive.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Jan 26, 2024)
Colgate-Palmolive Company (CL) filed an 8-K on January 26, 2024, primarily to announce its financial results for the fourth quarter and full year ended December 31, 2023. The core of this filing is a press release (Exhibit 99) which provides the detailed earnings information. Investors should refer to this press release for specifics on revenue, profitability, and any forward-looking guidance the company may have issued.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Oct 27, 2023)
Colgate-Palmolive Company (CL) filed an 8-K on October 27, 2023, primarily to report its financial results for the quarter ended September 30, 2023. The company issued a press release on October 27, 2023, which contains the details of these earnings. This filing serves as notification to investors about the company's performance during the third quarter of 2023. Investors should refer to the attached press release (Exhibit 99) for specific financial metrics, operational highlights, and management commentary regarding the company's performance. While this 8-K itself does not contain the detailed financial tables, it officially incorporates the press release by reference, making its content material for understanding CL's recent financial condition and operational results. The information provided is furnished and not deemed "filed" for certain legal purposes, which is a standard disclosure for earnings release attachments to an 8-K.
COLGATE PALMOLIVE CO 8-K Report, Executive Changes (Sep 15, 2023)
Colgate-Palmolive Company (CL) has filed an 8-K report detailing an amendment to its Executive Severance Plan. The Board of Directors renewed the plan on September 13, 2023, with a primary change requiring participating executives to agree to a one-year non-compete clause following termination of employment. This amendment aims to enhance employee retention and protect the company's competitive interests. The renewed plan will have an initial term of three years, with provisions for automatic one-year extensions unless the Board decides otherwise. This offers a degree of stability for executive compensation and benefits while also introducing a stronger commitment from executives to the company's ongoing success and market position. Investors should note this update as it pertains to executive compensation and potential future executive transitions.
COLGATE PALMOLIVE CO 8-K Report, Executive Changes (Aug 18, 2023)
Colgate-Palmolive Company (CL) has filed an 8-K report on August 18, 2023, to announce a change in its Board of Directors. Michael B. Polk has resigned from his position on the Board, effective August 18, 2023, citing personal reasons for his departure. This filing is primarily informational, detailing the resignation of a director. Investors should note that while any change in board composition can be a point of interest, the stated reason for Mr. Polk's resignation is personal, and no other immediate operational or financial implications are mentioned in this specific filing. The company will continue its business operations under the current management and board structure.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Jul 28, 2023)
Colgate-Palmolive Company (CL) filed a Current Report (8-K) on July 27, 2023, primarily to furnish a press release detailing its financial results for the quarter ended June 30, 2023. While the filing itself doesn't contain detailed financial tables, it serves as notification that the company has officially released its second-quarter earnings information to the public. Investors should refer to the attached press release (Exhibit 99) for the specific operational and financial performance metrics. The company is using this 8-K filing to comply with disclosure requirements, ensuring that material information regarding its financial condition and results of operations is made available. It is important to note that the information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated into other registration statements. Investors seeking detailed figures on revenue, profitability, segment performance, and forward-looking guidance must consult the referenced press release.
COLGATE PALMOLIVE CO 8-K Report, Shareholder Vote Results (May 17, 2023)
This 8-K filing from Colgate-Palmolive Co. (CL) details the results of their Annual Meeting of Stockholders held on May 12, 2023. The primary focus of the report is the outcome of various shareholder votes on critical corporate governance and compensation matters. Key outcomes include the overwhelming re-election of all eleven director nominees to the Board, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and the approval of the company's executive compensation plan on a non-binding advisory basis. Shareholders also voted to continue holding advisory votes on executive compensation annually. Conversely, two stockholder proposals, one concerning an independent Board Chairman and another regarding executives retaining significant stock, did not receive majority support.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Apr 28, 2023)
Colgate-Palmolive Company (CL) has filed an 8-K report on April 28, 2023, to announce its financial results for the quarter ended March 31, 2023. The primary purpose of this filing is to provide investors with the company's earnings performance and financial condition through an attached press release. This report is furnished and not deemed "filed" for certain regulatory purposes, meaning it doesn't trigger liabilities under Section 18 of the Securities Exchange Act of 1934 or get automatically incorporated into future registration statements. Investors should refer to Exhibit 99, the press release dated April 28, 2023, for the specific details of the first-quarter 2023 financial results. While this 8-K filing itself does not contain the detailed financial figures, it formally incorporates the press release, which is the source of truth for the company's performance during the period. This includes key metrics such as revenue, earnings per share, and any commentary on operational performance and outlook provided by the company's management.
COLGATE PALMOLIVE CO 8-K Report, Corporate Update (Mar 1, 2023)
Colgate-Palmolive Company (CL) has announced the successful issuance and sale of $1.5 billion in aggregate principal amount of senior notes. This offering includes $500 million of 4.800% Senior Notes due 2026, $500 million of 4.600% Senior Notes due 2028, and $500 million of 4.600% Senior Notes due 2033. The issuance was conducted under the company's existing shelf registration statement and was facilitated through an underwriting agreement with several prominent financial institutions. This debt issuance represents a significant capital raising activity for Colgate-Palmolive. Investors should note the specific interest rates and maturity dates for each tranche of notes, which provide a clear picture of the company's cost of borrowing and its long-term debt obligations. The use of proceeds is not detailed in this 8-K filing, but such actions typically support general corporate purposes, potential acquisitions, or refinancing existing debt.
COLGATE PALMOLIVE CO 8-K Report, Executive Changes (Jan 30, 2023)
Colgate-Palmolive Company (CL) announced a significant addition to its Board of Directors with the election of Steven Cahillane, effective February 1, 2023. Mr. Cahillane, currently the Chairman, President, and CEO of Kellogg Company, brings a wealth of experience in global consumer products and health and nutrition industries, which is highly relevant to Colgate's business. His appointment is expected to enhance the Board's strategic oversight and guidance as the company navigates the evolving consumer landscape.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Jan 27, 2023)
Colgate-Palmolive Company (CL) filed an 8-K on January 27, 2023, to report its financial results for the quarter and year ended December 31, 2022. The key information is disseminated via a press release, attached as Exhibit 99, which provides details on the company's performance during the period. Investors should note that the information furnished under Item 2.02 is for informational purposes and is not considered "filed" under Section 18 of the Securities Exchange Act of 1934, nor will it be incorporated into other SEC filings.
COLGATE PALMOLIVE CO 8-K Report, Bylaw Amendment (Jan 12, 2023)
Colgate-Palmolive Company (CL) has filed an 8-K report on January 12, 2023, detailing amendments to its Amended and Restated By-laws, effective January 12, 2023. These changes primarily focus on updating procedures for stockholder proposals, specifically concerning special meetings and director nominations. A key new requirement mandates that stockholders intending to nominate directors must disclose whether they plan to solicit proxies for at least 67% of the company's voting shares. Additionally, the by-laws have been updated to designate a Delaware state or federal court as the exclusive forum for certain legal actions against the company, including derivative suits and claims related to fiduciary duties. These amendments are largely technical and administrative, reflecting updates in line with new SEC universal proxy rules and aiming to streamline corporate governance processes. For investors, the changes mainly impact procedural aspects of engaging with the company for shareholder proposals and director nominations, as well as clarifying legal venue for specific types of lawsuits. The company has also included the full text of the amended by-laws as an exhibit for further review.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Oct 28, 2022)
Colgate-Palmolive Company (CL) filed an 8-K on October 28, 2022, to report its financial results for the third quarter ended September 30, 2022. The core of this filing is the press release announcing these results, which provides investors with the company's operational and financial performance during the period. While the 8-K itself does not contain detailed financial tables, it directs investors to the attached press release for the specifics of their quarterly performance. Investors should refer to the press release (Exhibit 99) for critical details such as revenue, earnings per share, segment performance, and any forward-looking statements or guidance provided by the company. This filing serves as a formal notification of the release of these important financial updates, enabling investors to assess Colgate-Palmolive's recent business activities and financial health.
COLGATE PALMOLIVE CO 8-K Report, Corporate Update (Aug 9, 2022)
Colgate-Palmolive Company (CL) announced the completion of its public offering of $1.5 billion in senior notes across three tranches: $500 million in 3.100% Senior Notes due 2025, $500 million in 3.100% Senior Notes due 2027, and $500 million in 3.250% Senior Notes due 2032. This offering, finalized on August 9, 2022, was conducted under the company's existing shelf registration statement filed in October 2020. The issuance of these notes indicates Colgate-Palmolive's proactive approach to managing its capital structure and potentially refinancing existing debt or funding general corporate purposes. Investors can view the terms of the notes and the governing indenture, which have been filed as exhibits with the SEC, to understand the specifics of the company's debt obligations.
COLGATE PALMOLIVE CO 8-K Report, Corporate Update (Aug 3, 2022)
Colgate-Palmolive Company (CL) has announced a significant debt financing initiative through an 8-K filing on August 3, 2022. The company entered into an underwriting agreement to issue and sell a total of $1.5 billion in senior notes across three tranches: $500 million of 3.100% Senior Notes due 2025, $500 million of 3.100% Senior Notes due 2027, and $500 million of 3.250% Senior Notes due 2032. This offering represents a strategic move to raise capital, likely to fund ongoing operations, potential acquisitions, or refinance existing debt. The specific use of proceeds is not detailed in this filing, but the issuance of long-term debt signals management's confidence in the company's ability to service its obligations and manage its capital structure effectively. Investors should note the terms of these notes, including coupon rates and maturity dates, as they will impact the company's leverage and interest expense in the coming years.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Jul 29, 2022)
Colgate-Palmolive Company (CL) filed an 8-K on July 29, 2022, to report its financial results for the quarter ended June 30, 2022. The primary purpose of this filing is to incorporate by reference the earnings press release issued on July 29, 2022. This press release contains the detailed financial performance and operational updates for the company during the second quarter of 2022. Investors should refer to the attached press release (Exhibit 99) for comprehensive information regarding Colgate-Palmolive's second-quarter performance, including revenue, profitability, and any management commentary on business trends, segment performance, and outlook. It's important to note that the information furnished under Item 2.02 is not deemed "filed" for regulatory purposes and does not carry the same liabilities as filed information, nor will it be automatically incorporated into future registration statements.
COLGATE PALMOLIVE CO 8-K Report, Executive Changes (Jun 13, 2022)
Colgate-Palmolive Company (CL) announced a change in its principal accounting officer, effective June 30, 2022. Gregory Malcolm has been elected Vice President and Controller, taking on the role of principal accounting officer. This transition signifies an internal promotion, as Mr. Malcolm has been with the company since 1999 and has held various significant financial positions, most recently as Vice President, Assistant Controller since October 2021. Philip G. Shotts, the outgoing Controller, will continue with the company in a new role as Senior Vice President, Finance. Investors should view this as a routine leadership change within the finance department, demonstrating a commitment to internal talent development. The company's operational and financial reporting continuity is expected to remain stable with Mr. Malcolm's appointment.
COLGATE PALMOLIVE CO 8-K Report, Shareholder Vote Results (May 11, 2022)
Colgate-Palmolive Company (CL) filed an 8-K report detailing the outcomes of its Annual Meeting of Stockholders held on May 6, 2022. The key takeaway for investors is the overwhelming approval of all management-proposed items, including the election of all nominated directors, the ratification of PricewaterhouseCoopers LLP as the independent auditor, and the advisory vote on executive compensation. This strong shareholder support across these critical governance and operational matters indicates continued confidence in the company's leadership and financial oversight. While two shareholder proposals did not pass, the significant majority voting in favor of management's agenda provides a stable and positive outlook regarding the company's governance structure and executive remuneration.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Apr 29, 2022)
Colgate-Palmolive Company (CL) has filed an 8-K report on April 29, 2022, to announce its first-quarter 2022 earnings results, which were detailed in a press release issued on the same date. This filing provides investors with key financial performance indicators and operational updates for the period ending March 31, 2022. The information furnished in this report is crucial for understanding the company's performance in a dynamic market environment and for assessing its future prospects. While the 8-K itself does not contain the detailed financial tables, it serves as the official notification that the press release, attached as Exhibit 99, contains the comprehensive earnings information. Investors should refer to this press release for specific figures on revenue, profitability, and other operational metrics that shape the company's financial condition. The filing also includes the standard Cover Page Interactive Data File.
COLGATE PALMOLIVE CO 8-K Report, Executive Changes (Apr 11, 2022)
Colgate-Palmolive Company (CL) filed an 8-K on April 11, 2022, announcing a significant change in its executive compensation policy regarding severance packages. Following engagement with its stockholders, the Board of Directors adopted a new policy on April 8, 2022, that limits cash severance benefits for executive officers. Specifically, new severance agreements will not exceed 2.99 times the sum of the executive officer's base salary plus their target annual bonus opportunity, unless the agreement is ratified by stockholders.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Jan 28, 2022)
Colgate-Palmolive Company (CL) filed an 8-K on January 28, 2022, reporting on its financial results for the quarter and year ended December 31, 2021, via an attached press release. The filing also announced the approval of a "2022 Global Productivity Initiative" by the Board of Directors, designed to reallocate resources, drive operational efficiencies, and streamline the supply chain to reduce structural costs. This initiative is expected to incur pre-tax charges between $200 million and $240 million, substantially completed by the end of 2022, with approximately 90% of these charges resulting in cash expenditures. These charges will be recorded in the Corporate segment and will not impact internal segment operating performance measures. While the press release attached as Exhibit 99 contains details on the company's performance, the 8-K itself primarily focuses on the operational restructuring. Investors should note that the information furnished under Item 2.02 is not considered "filed" and is not subject to the same liability provisions as other filed information. The company has also included forward-looking statements regarding the productivity initiative, cautioning that actual results may differ due to various risks and uncertainties.
COLGATE PALMOLIVE CO 8-K Report, Bylaw Amendment (Dec 9, 2021)
Colgate-Palmolive Company (CL) announced on December 9, 2021, that its Board of Directors has approved amendments to its Amended and Restated By-laws. The most significant change is the reduction of the ownership threshold required for stockholders to call a special meeting, lowering it from 25% to 15% of the Company's outstanding common stock, provided that such ownership has been held for at least one year. This amendment follows a stockholder proposal at the 2021 Annual Meeting that garnered majority support for a lower threshold. The Company engaged with its largest institutional investors, representing a substantial portion of its outstanding shares, to gather feedback. The Board's decision to set the new threshold at 15% reflects a compromise and aims to align with the majority sentiment expressed by key stakeholders and the broader investor base, balancing the desire for increased shareholder voice with the need for responsible governance.
COLGATE PALMOLIVE CO 8-K Report, Corporate Update (Nov 10, 2021)
Colgate-Palmolive Company (CL) has filed an 8-K report detailing the completion of its previously announced public offering of €500,000,000 in aggregate principal amount of 0.300% Senior Notes due 2029. The offering, which was made under the company's shelf registration statement, closed on November 10, 2021. This move indicates proactive capital management and a strategy to potentially leverage favorable interest rate environments for long-term financing. Investors should note that the issuance of these senior notes at a low coupon rate of 0.300% suggests the company's strong credit standing and its ability to secure debt financing at attractive terms. The details of the indenture and the form of the notes have been filed as exhibits, providing transparency into the terms of this significant debt issuance. This event is primarily a financing activity and does not inherently signal operational changes or new business developments.
COLGATE PALMOLIVE CO 8-K Report, Corporate Update (Nov 5, 2021)
Colgate-Palmolive Company (CL) has filed an 8-K report detailing a public offering of senior notes. On November 3, 2021, the company entered into an underwriting agreement for the sale of €500,000,000 aggregate principal amount of 0.300% Senior Notes due 2029. This offering is expected to close around November 10, 2021. This debt issuance, made under the company's existing shelf registration statement, is a standard capital markets transaction. Investors should note the specific terms of the notes, including the coupon rate and maturity date, as well as the customary representations, warranties, and indemnification clauses present in the underwriting agreement. The filing indicates a routine financing activity aimed at managing the company's capital structure.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Oct 29, 2021)
Colgate-Palmolive Company (CL) filed an 8-K on October 29, 2021, to report its financial results for the quarter ended September 30, 2021. The core of this filing is the press release announcing these quarterly earnings, which is incorporated by reference. Investors should refer to the attached press release for detailed financial performance and operational updates for the period. This filing serves as the official notification mechanism for these results, as per SEC regulations. The company has explicitly stated that the information furnished under Item 2.02 is not considered "filed" for certain legal purposes, meaning it doesn't trigger liabilities under Section 18 of the Exchange Act of 1934 and won't be automatically incorporated into future SEC filings like registration statements unless explicitly stated. Investors should understand this distinction when evaluating the provided financial information.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Jul 30, 2021)
Colgate-Palmolive Company (CL) filed an 8-K on July 30, 2021, primarily to report its earnings for the quarter ended June 30, 2021. The key information is contained within the press release attached as Exhibit 99, which provides the company's operational and financial results for the period. Investors should review this press release for details on sales, profitability, and any management commentary regarding performance and outlook. This filing serves as notification of the earnings release and does not contain new, material operational or strategic updates beyond what was disclosed in the press release itself. As such, investors should look to the content of the July 30, 2021, press release for the specific financial figures and performance indicators relevant to the second quarter of 2021.
COLGATE PALMOLIVE CO 8-K Report, Corporate Update (Jul 22, 2021)
Colgate-Palmolive Company (CL) has filed an 8-K report on July 22, 2021, to announce its official recommendation regarding a "mini-tender" offer made by TRC Capital Investment Corporation. The company's management has reviewed this offer and is providing its guidance to shareholders. Investors should pay close attention to the company's stance, as it directly impacts the decision-making process for those holding CL shares and considering participation in the unsolicited offer. The primary purpose of this filing is to inform shareholders about Colgate-Palmolive's official position on the TRC Capital Investment Corporation's mini-tender offer. This recommendation, detailed in an attached press release, is crucial for investors to understand before making any decisions about tendering their shares. The company's advice aims to protect shareholder interests, and its content should be carefully reviewed.
COLGATE PALMOLIVE CO 8-K Report, Regulation FD Disclosure (Jun 10, 2021)
Colgate-Palmolive Company (CL) filed an 8-K on June 9, 2021, primarily to address a technological issue that prevented the simultaneous webcast of its CEO's fireside chat at the dbAccess Global Consumer Conference on June 8, 2021. The full presentation materials are now available on the company's investor relations website, allowing investors to access the information that was intended to be shared during the live event. While the filing itself does not contain new financial or operational disclosures, it serves to ensure all interested parties have equal access to the company's strategic discussions. Investors interested in Colgate-Palmolive's forward-looking statements and management commentary presented at the conference should refer to the supplemental materials posted on their website.
COLGATE PALMOLIVE CO 8-K Report, Shareholder Vote Results (May 13, 2021)
Colgate-Palmolive Company (CL) filed an 8-K on May 13, 2021, detailing the outcomes of its Annual Meeting of Stockholders held on May 7, 2021. The report indicates overwhelming support from shareholders for the election of all director nominees and the ratification of PricewaterhouseCoopers LLP as the independent auditor for the fiscal year ending December 31, 2021. Additionally, the advisory vote on executive compensation received majority approval, signaling shareholder confidence in the company's compensation practices. While the company's management-supported proposals sailed through with strong backing, two shareholder proposals garnered mixed results. The proposal for an independent Board Chairman was not approved, but a proposal to lower the ownership threshold for calling special stockholder meetings to 10% did receive majority support. These outcomes provide insights into shareholder sentiment on corporate governance and operational matters.
COLGATE PALMOLIVE CO 8-K Report, Financial Results (Apr 30, 2021)
Colgate-Palmolive Company (CL) filed an 8-K on April 30, 2021, to report its financial results for the first quarter ended March 31, 2021. The core of the filing is a press release announcing these results, which provides investors with the company's performance metrics for the period. While the filing itself is brief, the attached press release (Exhibit 99) contains the detailed financial data investors would need to assess the company's operational health and financial condition.
COLGATE PALMOLIVE CO 8-K/A Report, Financial Results (Apr 30, 2021)
Colgate-Palmolive Company (CL) filed an 8-K/A on April 29, 2021, primarily to incorporate by reference a press release dated April 30, 2021, announcing its earnings for the quarter ended March 31, 2021. Investors should review the attached press release (Exhibit 99) for detailed financial performance and operational updates for the first quarter of 2021. The filing itself does not contain new substantive financial details beyond directing readers to the press release.